(182 days)
Not Found
No
The device description focuses on the material, physical design, and mechanical function of the implant and associated instruments. There is no mention of software, algorithms, data processing, or any terms related to AI or ML.
Yes
The device is indicated to aid in the fixation of fractures, fusions, and osteotomies, which are therapeutic interventions.
No
The device is an intraosseous fixation system designed to aid in the fixation of fractures, fusions, and osteotomies of the toes. Its purpose is to physically fix and stabilize bones, rather than to diagnose medical conditions or diseases.
No
The device description clearly states the device is manufactured from implant grade PEEK and describes physical components like barbs and a hole, indicating it is a physical implant, not software.
Based on the provided information, the CrossTie™ Intraosseous Fixation System is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD devices are used to examine specimens derived from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- The CrossTie™ system is an implantable device used to physically fix fractures, fusions, and osteotomies within the toes. It is a surgical device, not a diagnostic one.
The description clearly outlines its use in surgical procedures and its physical characteristics as an implant. There is no mention of it being used to analyze biological samples.
N/A
Intended Use / Indications for Use
The CrossTie™ Intraosseous Fixation System is indicated to aid in the fixation of fractures, fusions, and osteotomies of the toes, such as hammertoe, claw toe, mallet toe and inter-digital fusions.
Product codes (comma separated list FDA assigned to the subject device)
HWC
Device Description
The CrossTie™ Intraosseous Fixation System is manufactured from implant grade PEEK. The implant is a one-piece construct designed to be press-fit into the intraosseous space of two adjoining bones to aid in fusion. The proximal and distal ends of the implant have barb-type features for securing the implant in position. The implant also features a hole in the distal end of the implant to be used at the surgeon's discretion to assist in joint reduction.
The instruments needed for implantation consist of a reamer for implant site preparation and a driver for insertion. All associated instruments are Class I.
The design features of the CrossTie™ Intraosseous Fixation System are summarized below:
- Implant Grade PEEK
- Sized to accommodate patient anatomy
- Solid, one piece construction for all devices
- Proximal and distal barb-like features for secure placement
- Hole to optionally aid in joint reduction
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
toes
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The CrossTie™ Intraosseous Fixation System device utilizes materials and has design features that are the same as the predicate devices. Evaluation of the material and dimensions demonstrates that the subject device has substantially equivalent rigidity to the predicate devices. The implant has been cyclic tested to demonstrate that the device can withstand the expected loads.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K133636, K113006, K120165, K073674
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized human figure in profile, with three overlapping faces or heads. The symbol is meant to represent the department's mission of protecting the health of all Americans and providing essential human services.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
January 8, 2015
OrthoDiscovery Group, LLC (D.B.A. CrossRoads Extremity Systems) Mr. Vernon R. Hartdegen Senior Vice President of Operations 458 Distribution Parkway Collierville, Tennessee 38017
Re: K141857
Trade/Device Name: CrossTie™ Intraosseous Fixation System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: Class II Product Code: HWC Dated: December 2, 2014 Received: December 5, 2014
Dear Mr. Hartdegen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
1
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Lori A. Wiggins -S
for Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use Statement
510(k) Number (if known): K141857 (page 1/1)
Device Name: CrossTie™ Intraosseous Fixation System
Indications for Use:
The CrossTie™ Intraosseous Fixation System is indicated to aid in the fixation of fractures, fusions, and osteotomies of the toes, such as hammertoe, claw toe, mallet toe and inter-digital fusions.
Prescription Use | X |
---|---|
(Part 21 CFR 801 Subpart D) |
AND/OR
Over-The-Counter Use | |
---|---|
(21 CFR 801 Subpart C) |
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation ndication for Use Statement
3
Date of Submission | December 2, 2014 |
---|---|
Official Contact/Address of | |
Manufacturing Facility | Vernon R Hartdegen |
Sr. Vice President of Operations | |
OrthoDiscovery Group LLC | |
6055 Primacy Parkway, Suite 140 | |
Memphis, TN 38119 |
Phone: 901-221-8406
Fax: n/a
vhartdegen@crextremity.com |
| Proprietary Name | CrossTie™ Intraosseous Fixation System |
| Device Classification Name | Smooth or threaded metallic bone fixation fastener |
| Classification Reference | 21 CFR 888.3040 |
| Classification | Class II |
| Appropriate Classification Panel | 87 - Orthopedic |
| Predicate Devices | K133636 – HammerFix IP Fusion System (Extremity Medical)
K113006 – PhaLinx Hammer Toe System (OrthoPro)
K120165 - CannuLink Instraosseous Fixation System (Orthohelix)
K073674 – Kirchner Wires (Signal Medical Corp) |
| Reason For Submission | New Device |
5 - 510(k) Summary CrossTie™ Intraosseous Fixation System
Substantial Equivalence:
The new device has the following similarities to the previously cleared predicate device:
- o Same Operating Principle
- Same Technology o
- Same Intended Use o
Design verification analysis was performed on the CrossTie™ Intraosseous Fixation System as a result of the risk analysis and product requirements. All analyses were verified to meet the required acceptance criteria. The subject device is most similar in material, indications and technical characteristics to the HammerFix (K133636 – Extremity Medical) predicate. It is similar in indications to the PhaLinx Hammer Toe (K113006 – OrthoPro) and the CannuLink System (K120165 – Orthohelix) but is not manufactured from titanium alloy. The subject CrossTie™ implant does not have a split end as the previously mentioned predicates (K133636 –
4
HammerFix IP Fusion System; K113006 – PhaLinx Hammer Toe System; & K120165 – CannuLink Instraosseous Fixation System). The non-split end of the CrossTie™ implant is intended to ensure a more predictable interface with the bone. Even though, there are minor differences between the subject and predicate devices, those differences are insignificant in the safety and efficacy of the devices. In summary, the subject device described in this submission is substantially equivalent to the predicate devices.
Indications for Use:
The CrossTie™ Intraosseous Fixation System is indicated to aid in the fixation of fractures, fusions, and osteotomies of the toes, such as hammertoe, claw toe, mallet toe and interdigital fusions
Device Description:
The CrossTie™ Intraosseous Fixation System is manufactured from implant grade PEEK. The implant is a one-piece construct designed to be press-fit into the intraosseous space of two adjoining bones to aid in fusion. The proximal and distal ends of the implant have barb-type features for securing the implant in position. The implant also features a hole in the distal end of the implant to be used at the surgeon's discretion to assist in joint reduction.
The instruments needed for implantation consist of a reamer for implant site preparation and a driver for insertion. All associated instruments are Class I.
The design features of the CrossTie™ Intraosseous Fixation System are summarized below:
- Implant Grade PEEK o
- Sized to accommodate patient anatomy O
- O Solid, one piece construction for all devices
- Proximal and distal barb-like features for secure placement o
- Hole to optionally aid in joint reduction O
Performance Testing:
The CrossTie™ Intraosseous Fixation System device utilizes materials and has design features that are the same as the predicate devices. Evaluation of the material and dimensions demonstrates that the subject device has substantially equivalent rigidity to the predicate devices. The implant has been cyclic tested to demonstrate that the device can withstand the expected loads.